Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on FcRn-blocking therapies in neurology!
Andrea Rossetti, MD, director of the EEG/Epilepsy Unit at the Department of Clinical Neurosciences the Lausanne University Hospital in Switzerland, offers insight into post-resuscitation epilepsy care.
Here's some of what is coming soon to NeurologyLive® this week.
Orelabrutinib Achieves Primary Endpoint in Phase 2b SLE Trial
Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal
Phase 3 VALIANT Results for Pegcetacoplan In C3G, IC-MPGN, With Andrew Bomback, MD
Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible
1.
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis
2.
Chromatin organization linked to p53 tumor suppression mechanism
3.
Common intracellular toxin could help fight leukemia
4.
Cancer After Weight Loss; How Older Adults Use the Healthcare System.
5.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
1.
Exploring The Causes and Consequences of Low Transferrin Saturation
2.
Beyond the Battle: Navigating Life After Cancer
3.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
4.
The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium
5.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge